Q2 2025 Management View CEO Michael Patrick Lyons highlighted a strong quarter, stating, "we grew sales, clients and our new ...

Fiserv, Inc. (FI) stock has declined by over 13% in the last week since its Q2 earnings were released. But was it really all ...

Fiserv targeted 2025 earnings in a range between $10.15 and $10.30 a share, boosting the lower end of its previous target by 5 cents a share. The company tightened its sales target, and now ...

Fiserv stock fell after reporting Q2 2025 results, beating revenue and EPS estimates. Expanded in Canada with TD Bank agreement and acquisition.

Analysts expect Fiserv to report an earnings per share (EPS) of $2.43. The market awaits Fiserv's announcement, with hopes ...

Fiserv, Inc. is a top buy: double-digit growth, margin expansion, global Clover rollout, innovative solutions, and undervalued at 15x FCF. Click for more on FI.

Fiserv reported an impressive 8% growth in adjusted and organic revenue, coupled with a robust 16% increase in adjusted earnings per share (EPS) for the second quarter of 2025. The company’s adjusted ...

Fiserv stock plunged over 16% despite beating Q2 earnings expectations, as the company lowered its full-year organic revenue growth guidance and showed weakness in its merchant solutions segment ...

Adjusted EPS rose 16% to $2.47 in Q2 2025, topping analyst expectations of $2.44 (non-GAAP). Revenue increased 8% to $5.2 billion in Q2 2025, exceeding the $5.19 billion consensus. Management refined ...

Fiserv (FI) stock sold off 21% on Wednesday after the payments company reported a decent second quarter that didn't live up to expectations. The company missed Wall Street's organic sales growth in Q2 ...

Fiserv Inc. falsely represented that new customers, rather than cost-conscious users of its discontinued payment processing system, were driving revenue growth for the software maker, an investor ...

The primary catalyst for Wednesday’s selloff was Fiserv’s decision to narrow its full-year 2025 organic revenue growth outlook to “approximately 10%” from its previous guidance range of 10% to 12%.